GABA AgonistsBenzodiazepinesMuscimolGABA-A Receptor AgonistsReceptors, GABA-AGABA Antagonistsgamma-Aminobutyric AcidBaclofenAnti-Anxiety AgentsDiazepamBicucullineGABA ModulatorsGABA-B Receptor AgonistsChlordiazepoxidePicrotoxinIsoxazolesAlprazolamFlunitrazepamHypnotics and SedativesLorazepamGABA AgentsFlumazenilOxazepamNitrazepamAzabicyclo CompoundsClonazepamBenzodiazepinonesNordazepamMicroinjectionsFlurazepamRats, Sprague-DawleyMidazolamTemazepamEnzyme Multiplied Immunoassay TechniqueNeuronsSubstance Abuse DetectionGABA Plasma Membrane Transport ProteinsCarbolinesDopamine AgonistsGABA-A Receptor AntagonistsReceptors, GABA-BForensic MedicineBarbituratesDose-Response Relationship, DrugBromazepamGABA Uptake InhibitorsTriazolamPregnanoloneAnticonvulsantsPsychotropic DrugsDrug InteractionsDrug OverdoseDrug PrescriptionsSubstance Withdrawal SyndromeFluorescence Polarization ImmunoassayClorazepate DipotassiumPatch-Clamp TechniquesPurinergic P1 Receptor AgonistsSubstance-Related DisordersPyridazinesRadioligand AssayPentobarbitalNipecotic AcidsNarcoticsTranquilizing AgentsMuscarinic AgonistsGas Chromatography-Mass SpectrometryNicotinic AgonistsPentylenetetrazoleInappropriate PrescribingPregnanedionesConvulsantsSleep Initiation and Maintenance DisordersStreet DrugsDrug UtilizationAntidepressive AgentsSynaptic TransmissionAdrenergic alpha-2 Receptor AgonistsAdrenergic AgonistsRats, WistarSerotonin 5-HT2 Receptor AgonistsPhosphinic AcidsAdrenergic alpha-AgonistsPyridinesNeural InhibitionSerotonin 5-HT1 Receptor AgonistsHippocampusGABA-B Receptor AntagonistsHistamine AgonistsAnxiety DisordersProtein SubunitsEndrinStatus EpilepticusBehavior, AnimalDrug TolerancePurinergic P2 Receptor AgonistsHeptachlor EpoxideAntipsychotic AgentsTime FactorsExcitatory Amino Acid Agonists